Φιλτράρισμα ανά Last updated date SelectΜετάΠρινFrom - To Date Ημερομηνία λήξης This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationMedical devicesScientific adviceMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate usePRIMECareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Leave this field blank Filter Αποτελέσματα (3846) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank Mylan S.A.S. withdraws its marketing authorisation application for Docetaxel Mylan (docetaxel) 15 Μάρτιος 2010Press release Committee for Medicinal Products for Veterinary Use (CVMP): Meeting of 9-11 March 2010 12 Μάρτιος 2010Press releaseVeterinary Ark Therapeutics Ltd withdraws its marketing authorisation application for Cerepro (sitimagene ceradenovec) 11 Μάρτιος 2010Press release Food and Drug Administration and European Medicines Agency agree to accept a single orphan drug designation annual report 26 Φεβρουάριος 2010Press releaseMedicines European Medicines Agency updates on pandemic influenza 19 Φεβρουάριος 2010Press releaseMedicines Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP), 15-18 February 2010 19 Φεβρουάριος 2010Press releaseHuman United Therapeutics Europe Ltd withdraws its marketing authorisation application for Tyvaso 19 Φεβρουάριος 2010Press release European Medicines Agency recommends contraindication for Regranex in patients with any pre-existing cancer 18 Φεβρουάριος 2010Press releaseMedicines European Medicines Agency and EUnetHTA Joint Action start collaboration on European Public Assessment Report (EPAR) contribution to relative effectiveness assessments 16 Φεβρουάριος 2010Press releaseMedicines European Medicines Agency and Swissmedic agree sharing of information on H1N1 pandemic medicines 15 Φεβρουάριος 2010Press releaseMedicines 1 … 294 295 296 297 298 Page 298 of 385 299 300 301 302 … 385
Mylan S.A.S. withdraws its marketing authorisation application for Docetaxel Mylan (docetaxel) 15 Μάρτιος 2010Press release
Committee for Medicinal Products for Veterinary Use (CVMP): Meeting of 9-11 March 2010 12 Μάρτιος 2010Press releaseVeterinary
Ark Therapeutics Ltd withdraws its marketing authorisation application for Cerepro (sitimagene ceradenovec) 11 Μάρτιος 2010Press release
Food and Drug Administration and European Medicines Agency agree to accept a single orphan drug designation annual report 26 Φεβρουάριος 2010Press releaseMedicines
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP), 15-18 February 2010 19 Φεβρουάριος 2010Press releaseHuman
United Therapeutics Europe Ltd withdraws its marketing authorisation application for Tyvaso 19 Φεβρουάριος 2010Press release
European Medicines Agency recommends contraindication for Regranex in patients with any pre-existing cancer 18 Φεβρουάριος 2010Press releaseMedicines
European Medicines Agency and EUnetHTA Joint Action start collaboration on European Public Assessment Report (EPAR) contribution to relative effectiveness assessments 16 Φεβρουάριος 2010Press releaseMedicines
European Medicines Agency and Swissmedic agree sharing of information on H1N1 pandemic medicines 15 Φεβρουάριος 2010Press releaseMedicines